Back to
Wells Fargo & Company
ONCY
Showing 8 of 28 quarters
Position history for
Wells Fargo & Company's holdings in Oncolytics Biotech Inc.
As of its Q1 2026 13F, Wells Fargo held 6,602 shares of ONCY (Oncolytics Biotech), worth $5,604. Wells Fargo's 13F filings listed ONCY from Q3 2019 to Q1 2026, 27 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$3,833
Total Shares Change
-4,401
Quarter-by-Quarter History